ERDERA will launch its Clinical Trial Call
2026 on 1 July 2026, supporting
multinational Phase I–II clinical trials in
rare diseases. The call promotes
collaborative studies across countries,
focusing on areas of high unmet medical
need, and follows a multi-stage
application process starting with a mandatory Expression of Interest.
Join the information webinar on 6 July 2026 (15:00–17:00 CEST)
Read full details on eligibility, scope, and application process: Call Tex

READ MORE